Zobrazeno 1 - 10
of 4 143
pro vyhledávání: '"INFLAMMATORY breast cancer"'
Autor:
Quirindongo-Rivera, Camiled1,2, Rullán-Varela, Valeria3, Underill, Zoe4, Rivera, Mayra5, Ortiz-Ortiz, Karen J.1,6, Martínez-Montemayor, Michelle M.3 michelle.martinez@uccaribe.edu
Publikováno v:
Journal of Cancer. 2022, Vol. 13 Issue 14, p3495-3502. 8p.
Autor:
François Bertucci, Arnaud Guille, Florence Lerebours, Michele Ceccarelli, Najeeb Syed, José Adélaïde, Pascal Finetti, Naoto T. Ueno, Steven Van Laere, Patrice Viens, Alexandre De Nonneville, Anthony Goncalves, Daniel Birnbaum, Céline Callens, Davide Bedognetti, Emilie Mamessier
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Neoadjuvant chemotherapy (NACT) became a standard treatment strategy for patients with inflammatory breast cancer (IBC) because of high disease aggressiveness. However, given the heterogeneity of IBC, no molecular feature reliably
Externí odkaz:
https://doaj.org/article/1068ae1848944ff180c01ffd49e76be5
Autor:
CHEN Shuyu, GAO Ya
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 10, Pp 1506-1510 (2024)
"Objective To investigate the clinicopathological features and survival prognostic factors of patients with triple-negative inflammatory breast cancer (TNIBC). Methods The data of patients with TNIBC from 2010 to 2015 were obtained from SEER database
Externí odkaz:
https://doaj.org/article/cc34fbe0d73d4135929969195959ed3e
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1157-1165 (2024)
Introduction: Inflammatory breast cancer is a rare and aggressive subtype, with high breast cancer mortality. Compared to noninflammatory breast cancer, even after treatment and response to standard-of-care breast cancer chemotherapy, it has a high p
Externí odkaz:
https://doaj.org/article/a4e1aeadd96344279c198877879ca220
Autor:
Naiade Calanca, Flavia Lima Costa Faldoni, Cristiano Pádua Souza, Jeferson Santos Souza, Bianca Elen de Souza Alves, Milena Botelho Pereira Soares, Deysi Viviana Tenazoa Wong, Roberto César Pereira Lima-Junior, Fabio Albuquerque Marchi, Claudia Aparecida Rainho, Silvia Regina Rogatto
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Although the clinical signs of inflammatory breast cancer (IBC) resemble acute inflammation, the role played by infiltrating immune and stromal cells in this aggressive disease is uncharted. The tumor microenvironment (TME) presen
Externí odkaz:
https://doaj.org/article/7c7f9e10179346a1b0da0fcab74047f7
Autor:
Yiwei Jia, Chaofan Li, Cong Feng, Shiyu Sun, Yifan Cai, Peizhuo Yao, Xinyu Wei, Zeyao Feng, Yanbin Liu, Wei Lv, Huizi Wu, Fei Wu, Lu Zhang, Shuqun Zhang, Xingcong Ma
Publikováno v:
Translational Oncology, Vol 52, Iss , Pp 102246- (2025)
Background: Inflammatory breast cancer (IBC) is an aggressive and rare phenotype of breast cancer, which has a poor prognosis. Thus, it is necessary to establish a novel predictive model of high accuracy for the prognosis of IBC patients. Methods: Cl
Externí odkaz:
https://doaj.org/article/c9d3a99234f947da981f1bd972ec3a55
Publikováno v:
Sanamed, Vol 19, Iss 1, Pp 71-77 (2024)
Inflammatory breast cancer in males is an uncommon but extremely aggressive form of the disease. It is often misdiagnosed as a benign skin disease since it manifests as erythema along the chest wall. The management guidelines are not specific, and tr
Externí odkaz:
https://doaj.org/article/90e29c4db72f4f17ade37205a57b160b
Autor:
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti, José Adélaïde, Steven Van Laere, Anthony Goncalves, Patrice Viens, Daniel Birnbaum, Emilie Mamessier, Céline Callens, Davide Bedognetti
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Inflammatory breast cancer (IBC) is the most pro-metastatic form of BC. Better understanding of its enigmatic pathophysiology is crucial. We report here the largest whole-exome sequencing (WES) study of clinical IBC samples. Metho
Externí odkaz:
https://doaj.org/article/d411209f682649f3b4011eb089a7cbba
Publikováno v:
European Journal of Breast Health. Oct2018, Vol. 14 Issue 4, p229-233. 5p.
Autor:
Çakar, Burcu1 burcu.cakar@gmail.com, Sürmeli, Zeki2, Öner, Pınar Gürsoy3, Yelim, Elif Sıla4, Karabulut, Bülent1, Uslu, Ruchan1
Publikováno v:
European Journal of Breast Health. Oct2018, Vol. 14 Issue 4, p211-217. 7p.